A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
Clinical trial NCT05316220 · WITHDRAWN
Trial details
- NCT number
- NCT05316220
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2026-07-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.